-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psychiatric-readmissions_disposition-comments.pdf
May 21, 2015 - Predicting readmission to the psychiatric hospital in a managed
care environment: implications for quality indicators … Might proove useful to collect information from clients
regarding what works. … to client. … KIs noted that in many
cases, patients are discharged from psychiatric hospitals as soon as the
safety … Patient- and practice-related
determinants of emergency department length of stay for patients with
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-disposition-comments.pdf
October 01, 2021 - reconstruction could
mislead healthcare providers who rely on this report for
information about the safety … , sexual well-
being, and patient satisfaction,
were of interest. … , sexual well-
being, and patient satisfaction,
were of interest. … We involved patient stakeholders
as Key Informants in the project. … and standard instrument
that is self-reported by patients.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - hospitals)
Health Technology Assessment Information Service ECRI Database (information on clinical, safety … sales and a cost of $69,000 per patient treated, we estimated that about 1,600 patients
per year are … Based on potential initial adoption of about 10% (i.e.,
about 800,000 patients) of the eligible patient … As this technology matures and additional long-term safety and efficacy data
are available, we anticipate … If all patients with the G551D mutation receive
ivacaftor at the retail cost of about $324,600 per patient
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
January 01, 2011 - • Reviewers should assess whether benefits or harms vary along with differences in patient
or intervention … Finally, intervention features may affect the ability to generalize the effectiveness or
safety of the … in each trial, can be prone to bias (the “ecological fallacy”).37 Meta-analysis based on
individual-patient … features, inspect whether this variation is
associated with differences in measures of effectiveness or safety … systematic reviews which address relatively broad clinical or policy questions in representative
patient
-
effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
January 01, 2011 - • Reviewers should assess whether benefits or harms vary along with differences in patient
or intervention … Finally, intervention features may affect the ability to generalize the effectiveness or
safety of the … in each trial, can be prone to bias (the “ecological fallacy”).37 Meta-analysis based on
individual-patient … features, inspect whether this variation is
associated with differences in measures of effectiveness or safety … systematic reviews which address relatively broad clinical or policy questions in representative
patient
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Although propofol may be preferred for these
reasons, safety concerns complicate its use. … the Sedasys can be used.7
The FDA approval requires that EES conduct two postmarketing studies on safety … Clinicians can access
objective, accurate, and timely data about patient adherence, to monitor patients … It may be
12
solely age-based (i.e., patients 65 years and older) or also based on patient complaint … of certain diagnoses that are monitored as quality
improvement indicators.”68
Health disparities
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-207-ptsd-disposition-comments.pdf
May 17, 2018 - Could you
complete the arrow leading from "Patient
Characteristics...) to "Psychological or ....”? … The patient
characteristics of primary interest should be those known
or knowable BEFORE choice of … for
only then are such characteristics of use in choosing
which treatment might be best for which patient … Almost every
patient given treatment will be better off than every patient
given Control. … therapy or group present-
centered therapy
• Psychodynamic therapy
• PTSD family education
• Seeking Safety
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/anxiety-children_research-protocol.pdf
September 12, 2016 - There is a great deal of uncertainty regarding comparative effectiveness and safety of all
treatments … that are widely
available and validated; which are:(patients/parent reported and clinician assessed … What are the treatment burdens (for patients, providers, and health systems) and
contextual factors … specific phobias, generalized
• Animals
• Adults (age >= 18 years)
• Infants (age < 3 years)
• Patients … Evidence-Based Treatments for
Children and Adolescents: An Updated Review of Indicators of Efficacy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
May 01, 2012 - attention on the strength and limits of evidence from research studies about the effectiveness and
safety … For KQ 2, long-term effectiveness and safety studies of several psychostimulants in children
over the … Web-based prioritization exercises allowed each stakeholder to
distribute a limited number of star-shaped indicators … or patient derived information … Many patients and providers are
likely to switch treatments if patients experience harmful side effects
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - comparing DMB w ith placebo, and then extended
to collect eff icacy (BMD and bone turnover markers) and safety … , and therefore included a
mixture of patients w ith short- and long-term treatment. … differences in risk of harms betw een denosumab continuation
and discontinuation
vary as a function of patient … to add
substantial data about possible variation in various
harms as a function of a long list of patient … Results of
patient-level data from osteoporosis drug trials on the
association of early treatment changes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bariatric-surgery_research.pdf
June 01, 2010 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and … We tabulated the number of unique therapeutic classes of drug that the patient had ―on
hand‖ at the … If this supply would result in the patient having sufficient drug
―on hand‖ to overlap with a seven … day window surrounding the time point of interest, the patient
was considered to have been on this … utilization variables (hospitalizations, outpatient visits,
medical and pharmacy payments) and other indicators
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
October 05, 2015 - seclusion and
restraints must be used only for a behavior that “jeopardizes the immediate physical
safety … of the patient, a staff member, or others”5 (including other patients) and when less
restrictive measures … For patients
who are not acutely aggressive (i.e., not threatening the immediate physical safety of … Because of safety concerns in relation to aggressive behavior, our harms outcomes
are more inclusive … Patient!injury!or!
accidental!death,!staff!injury,!staff!distress,!
patient!psychological!trauma!
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
March 05, 2015 - Some of the trials including breast
cancer patients also included patients who did not have breast … It also shows that
results are independent of whether a patient has taken tamoxifen or
not. … cancer, and then exported to other
patients. … Page ES-14 Research Gaps: “These agents are unregulated and
safety data may be limited or absent.” … The authors’ actual conclusion
was that the safety data ARE limited or absent, not that they may be
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - If a patient has responded to one agent in the past, is that agent better than
current pharmacologic … KQ4a: For adults with a depressive syndrome, do second-generation antidepressants
differ in safety, … b: Are there any differences in safety, adverse events, or adherence between
immediate release and … symptoms (anxiety, insomnia, melancholia, pain, psychomotor changes, and
somatization), KQ4 focuses on safety … Because we do not have access to individual patient data, we will not conduct any
subgroup analyses.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-users-amended-protocol.pdf
June 21, 2019 - include at least annual assessments of the
functioning and fitting of the devices, ergonomics and safety … using a wheeled mobility device and to identify gaps for future research focus—
ultimately improving patient … Key Question 3: What are the patient factors that may affect the benefits and harms of
physical activity … For observational studies, we will
assess factors such as patient selection methods; attrition; accuracy … Prevalence of diabetes in patients with multiple sclerosis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
January 01, 2010 - Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness and Safety … However, the relative contribution of each of
these factors to the disease course varies by patient … rt-CGM differs from retrospective CGM in that it provides blood glucose feedback data to
the patient … In addition, several other factors appear to be especially relevant, including
the age of the patient … information about device use (e.g., analyses based on adherence to wearing
the device, training of patient
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
November 21, 2019 - or illness characteristics, recent
hospitalizations, indicators of serious illness or worsening of … This must include patient-reported
symptom measurement (or caregiver-reported for patients unable to … What context features might be important determinants of the
effectiveness of patient safety practice … BMJ quality & safety. 2011 Jul;20(7):611-7.
doi: 10.1136/bmjqs.2010.049379. PMID: 21617166.
21. … treatment options and preferences for future care.32
Triggers: Also known as screening criteria; indicators
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
January 01, 2014 - effectiveness and safety differ? … and safety differ? … and safety differ? … and
anticoagulant therapies in UA/NSTEMI patients, we
had to broaden our eligible patient population … acute coronary syndrome: a meta-analysis of
individual patient data.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
September 29, 2011 - What are the significant safety concerns associated with each treatment strategy (i.e., adverse
drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse
drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse
drug … volume, setting, guideline-based
treatment protocols)
Safety and adverse effects, including … The safety outcomes will be framed to help
identify adverse events, including adverse drug reactions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bereaved-persons-protocol.pdf
June 01, 2023 - experience
KQ2:
Diagnostic
accuracy
KQ3: Costs,
patient
experiences
KQ4:
Patient
experiences … will assess the effectiveness and any adverse events as well as the
comparative effectiveness and safety … We will
differentiate effectiveness and safety (compared to passive comparators such as no
screening … strategy, diagnostic test, or bereavement intervention) versus comparative
effectiveness and safety … Complicated grief and its correlates in
patients with bipolar disorder.